Ludwigshafen, Germany

Wolfgang Turk

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wolfgang Turk: Innovator in Schistosomicidal Compounds

Introduction

Wolfgang Turk is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of schistosomicidal agents. His work has implications for treating schistosomiasis, a disease caused by parasitic worms.

Latest Patents

Wolfgang Turk holds a patent for "Schistosomicidal acridanone hydrazones." This patent describes acridanone derivatives that are useful as schistosomicidal agents. The compounds outlined in his patent include various substituents that enhance their effectiveness in combating schistosomiasis. The patent details the processes for their preparation and the pharmaceutical compositions based on these compounds.

Career Highlights

Throughout his career, Wolfgang Turk has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has focused on innovative solutions to combat parasitic infections, showcasing his commitment to advancing medical science.

Collaborations

Wolfgang Turk has collaborated with notable colleagues such as Hermann Bretschneider and Marc Montavon. These partnerships have contributed to the development of effective pharmaceutical solutions.

Conclusion

Wolfgang Turk's contributions to the field of pharmaceuticals, particularly through his patent on schistosomicidal compounds, highlight his role as an innovator in medical science. His work continues to impact the treatment of parasitic diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…